Drug Trial Radar · NCT03034096
General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial
Last checked: Nov 19, 2026Latest source record: May 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,826
Actual
Start
Jan 31, 2017
Primary completion
Sep 30, 2024
Study completion Sep 30, 2024
Sponsor
- Lead sponsor
- Stony Brook UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 27, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a large pragmatic multicenter trial comparing maintenance of general anesthesia with total intravenous anesthesia using propofol versus volatile agent (sevoflurane, isoflurane, or desflurane) during cancer surgery. The primary endpoint is all-cause mortality.
Conditions
- Anesthesia, General
- Surgical Oncology
Interventions
PropofolDrug
Maintenance of general anesthesia with propofol infusion
Volatile AgentDrug
Maintenance of general anesthesia with volatile agent (sevoflurane, desflurane, or isoflurane)
Primary outcomes
What the sponsor says the trial is designed to measure.
- All-cause mortalityTime frame: 2 year minimum
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Roswell Park Cancer Center
Buffalo, New York
Long Island Jewish Medical Center
New Hyde Park, New York
Icahn School of Medicine at Mount Sinai
New York, New York
University of Rochester Medical Center
Rochester, New York
Stony Brook University Hospital
Stony Brook, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.